Clean Cells, established in 2000, is a GMP-licensed Contract Development and Manufacturing Organization (CDMO) specializing in the biopharmaceutical industry. With a mission defined by their slogan, "Solution for biologics," the company offers comprehensive services in R&D, production, and quality control testing.
Located in Western France, Clean Cells boasts facilities equipped with innovative process development platforms, BSL2 and BSL3 GMP manufacturing laboratories, and dedicated analytical areas. They are well-positioned within the biotechnological and healthcare sectors, leveraging the substantial capabilities and expertise of their sister company, Naobios, which is known for its proficiency in virus-based product manufacturing.
The last known funding event was a Venture Round investment on 03 December 2018, supported by ArchiMed. This infusion likely bolstered their capacity for innovation and service expansion, setting them up as a competitive player in the highly specialized biotech domain.